Fundraising Fox

Biotech Investors & VC Firms in Asia-Pacific

571 firms in this list, with a median first check of $650K. 110 of them lead rounds. Generated from verified public data and updated continuously.

Lang Sheng Investment Group Co. Ltd.
ShanghaiPre-Seed–Series B
7 people
Matrix Partners China
BeijingSeed–Late Stage$1.6M – $113M
6 people
SIDBI Venture Capital
MumbaiSeed–Late Stage
6 people
Mitsubishi UFJ Capital
TokyoPre-Seed–Late Stage$952K – $269M
5 people
Ming capital
ShenzhenSeed–Late Stage
6 people
TusStar
BeijingPre-Seed–Growth
Yali Capital
BengaluruPre-Seed–Late Stage
9 people
Birch Venture Capital, Inc.
Taipei CitySeed–Late Stage
3 people
Bharat Fund
AhmedabadPre-Seed–Series A
10 people
Jelix Ventures
SydneyPre-Seed–Series A
5 people
Partners Investment Co. Ltd.
SeoulSeries A–Late Stage
10 people
Aarin Capital
BangaloreSeed–Series A
5 people
Vertex Ventures HC
SingaporeSeed–Growth$500K – $10M
4 people
AddVentures by SCG
BangkokSeed–Late Stage$1.5M – $66M
6 people
Axia8 Ventures
ShanghaiPre-Seed–Series A$1M – $10M
6 people
Whiz Partners Inc.
TokyoSeed–Late Stage$500K – $5M
6 people
LYZZ Capital
ShanghaiSeed–Series A
5 people
Jumar Bioincubator
MelbournePre-Seed–Series A
9 people
Infotech Ventures
BeijingSeed–Late Stage
Vision Creator
SeoulPre-Seed–Late Stage
EDB Investments
SingaporeSeed–Late Stage$12M – $400M
11 people
TransPacific Venture Partners
Taipei CitySeed–Series B$500K – $3M
2 people
Centurium Capital
XiamenGrowth–Late Stage
3 people
Hillhouse Capital
ChangyangSeed–Series C$2.9M – $220M

Related lists

Data sourced from public filings and firms' own websites — see our methodology.